| Код ТН ВЭД | 833401 |
Как аккредитованный завод по производству лактидно-гликолидных кополимеров для медицинских устройств PURASORB PLG 8537, мы соблюдаем строгие протоколы качества - каждая партия подвергается строгим испытаниям для обеспечения последовательных стандартов эффективности и безопасности.
| Упаковка | |
| Доставка | |
| Хранение |
Конкурентоспособные цены на лактид-гликолидный кополимер для медицинских устройств PURASORB PLG 8537, которые соответствуют вашему бюджету - гибкие условия и индивидуальные котировки для каждого заказа.
Для получения образцов, цен или более подробной информации свяжитесь с нами по адресу +8618136850665 или отправить по почте admin@ascent-chem.com.
Мы ответим вам как можно скорее.
Телефон: +8618136850665
Электронная почта: admin@ascent-chem.com
Гибкие условия оплаты, конкурентоспособные цены, первоклассное обслуживание — обращайтесь прямо сейчас!
PURASORB PLG 8537 Medical Device Lactide-Glycolide Copolymer is a poly(L-lactide-co-glycolide) resin manufactured by Corbion under current Good Manufacturing Practice for absorbable implant components. The grade designation encodes the copolymer ratio and dilute-solution viscosity: 85 mol% L-lactide and 15 mol% glycolide, with a nominal inherent viscosity of 0.37 dL/g in chloroform at 25 °C and 0.1 g/dL. Release testing typically reports an inherent viscosity interval of 0.32 dL/g to 0.44 dL/g according to ISO 1628-1:2009. The material is intended for melt-based processing of medical devices such as sutures, clips, fixation pins, and other absorbable implants, and is supplied as white to off-white granules or powder in sealed, moisture-barrier packaging.
| Property | Specification | Test method |
|---|---|---|
| L-lactide molar content | 84–86 mol% | ¹H NMR, ISO 13781:2017 |
| Glycolide molar content | 14–16 mol% | Calculated from lactide content |
| Inherent viscosity | 0.32–0.44 dL/g | ISO 1628-1:2009, chloroform, 25 °C, 0.1 g/dL |
| Residual monomers | <0.5 wt% | Gas chromatography, ISO 13781:2017 |
| Water content | <0.5 wt% | ISO 15512 |
| Tin content | <50 ppm | ICP-OES |
| Sulfated ash | <0.1 wt% | ISO 3451-1 |
The hygroscopic character of the copolymer makes the water content specification a processing boundary rather than a simple quality attribute. Exposure to ambient air at relative humidity above 30% for more than 24 h can raise the moisture level above 0.1 wt%. Karl Fischer titration according to ISO 15512 is therefore performed immediately before drying and melt processing. When moisture is not controlled, hydrolysis during heating reduces molecular weight before the implant is formed, shifting the batch outside the viscosity range defined by the grade code.
The 0.37 dL/g inherent viscosity of the 8537 grade provides a lower melt viscosity than high-IV 85:15 PLG resins, allowing injection molding of thin-wall and complex-cavity parts on conventional equipment. Production-scale processing typically uses reciprocating-screw injection molding machines with clamp force between 50 t and 150 t. Barrel temperature profiles from feed to nozzle are maintained from 160 °C to 180 °C, and back pressure is limited to 5 MPa to reduce shear heating. Mold temperature is held below 30 °C because the high lactide content crystallizes slowly; rapid cooling produces a largely amorphous morphology with lower dimensional stability after sterilization and should be evaluated with differential scanning calorimetry according to ISO 11357-3.
Twin-screw compounding on a co-rotating extruder with a 25:1 L/D ratio is common when the resin is blended with radiopacifiers, plasticizers, or other absorbable polymers. The melt residence time is kept below 10 min because ester interchange and thermal depolymerization accelerate above 190 °C. Loss of molecular weight during processing is monitored by dilute-solution viscosity before and after extrusion; a decline greater than 10% from the starting IV indicates insufficient drying or excessive residence time. Vacuum venting at -0.08 MPa is used on open-vent barrels to remove residual monomer and low-molecular-weight volatiles. When the resin is processed on a 30 mm twin-screw line, feed zone temperatures below 150 °C prevent bridging in the hopper, while the melt zone is not allowed to exceed 180 °C to avoid the formation of lactide-rich volatile byproducts.
Solution processing is used when the device geometry cannot be achieved by melt routes. The copolymer is dissolved in chloroform or hexafluoroisopropanol at concentrations from 5 wt% to 15 wt%. Solvent removal under vacuum at 40 °C limits crystallization-induced brittleness. Residual solvent must be verified by headspace gas chromatography before final packaging because solvent residues above 0.1 wt% plasticize the copolymer and alter hydrolytic degradation kinetics. Electrospinning and dry-spinning require filtration through a 5 µm screen to remove gel particles that form when localized concentration gradients exceed the solubility limit.
Ethylene oxide sterilization can introduce humidity that accelerates hydrolysis of the 8537 resin unless the final device is preconditioned to a defined water activity. Validation according to ISO 11135:2014 requires residual ethylene oxide and ethylene chlorohydrin limits to be met before release. During sterilization, absorbed moisture reacts with the ester backbone, producing a measurable reduction in inherent viscosity. A drop of 0.02 dL/g to 0.05 dL/g after sterilization is common when the device is exposed to high relative humidity; this shift must be accounted for in the device design margin because it alters the initial molecular weight before implantation. Gamma sterilization is generally avoided for the 8537 grade unless the dose is limited below 25 kGy, because higher doses generate free radicals and drive chain scission that disproportionately affects the lower-IV grade relative to high-IV copolymers.
Hydrolytic degradation after implantation follows the standard ester hydrolysis pathway. The higher lactide content of the 8537 grade produces slower mass loss than a 50:50 PLG copolymer in phosphate-buffered saline at 37 °C under ASTM F1635-16. Mechanical strength retention is therefore extended relative to lower-lactide grades, but the exact strength retention time depends on part geometry, crystallinity, sterilization moisture, and implantation site. Published data for this specific configuration is limited; lot-specific degradation studies are required before assigning a resorption profile to a finished device.
| Requirement | Standard/designation | Applicability |
|---|---|---|
| Biological evaluation planning | ISO 10993-1:2018 | Final device |
| In vitro cytotoxicity | ISO 10993-5:2009 | Final device extract |
| Endotoxin limit | USP <85>, ANSI/AAMI ST72:2011 | Final device |
| Sterilization validation | ISO 11135:2014, ISO 11137-1:2006 | Final device |
| In vitro degradation | ASTM F1635-16, ISO 13781:2017 | Molded specimens |
Differences from other products in the PURASORB PLG range reduce to two variables: the lactide/glycolide molar ratio and the dilute-solution viscosity. A 50:50 PLG with the same 0.37 dL/g IV will lose molecular weight faster in aqueous degradation tests; an 85:15 PLG with a 0.8 dL/g IV will produce higher tensile strength after orientation but will require higher processing temperatures and torque. The 8537 grade occupies a middle processing position for thin-wall or complex-cavity devices that must retain tensile strength beyond 4 weeks under ASTM D638-14 testing. The resin should not be combined with amine-based processing aids, strong acids, or oxidizing agents because these accelerate chain scission and shift viscosity downward. Storage below -20 °C in sealed nitrogen-purged packaging is recommended. Once opened, the material should be dried and processed within 72 h at controlled humidity below 30%.